Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies
published in: Multiple Sclerosis and Related Disorders
date of publication: 2016-05-11
main subject: relapsing-remitting multiple sclerosis
Cites articles
There is nothing here
Article - wd:Q40535159